Investment Rating - The report does not explicitly state the investment rating for S'Yong Group Core Views - S'Yong Group achieved revenue of 2.5 billion yuan in the first half of 2025 (25H1), representing a year-on-year increase of 9.02%, driven by high-end brand development and global strategy optimization [2][7] - The company's proprietary brands generated operating revenue of 1.039 billion yuan, accounting for 41.55% of total revenue, with a gross margin of 76.83%, up 5.7 percentage points year-on-year [2][7] - Overall gross margin for 25H1 was 64.6%, an increase of 3.1 percentage points year-on-year, attributed to a higher proportion of high-end brands and optimization of low-efficiency businesses [2][7] - Net profit attributable to the parent company reached 123 million yuan, a year-on-year increase of 16.54%, with a net profit margin of 4.93% [2][7] Summary by Sections Financial Performance - In 25H1, S'Yong Group reported a net profit of 123 million yuan, a 16.54% increase year-on-year, with a net profit margin of 4.93% [2][7] - The second quarter of 2025 (25Q2) saw revenue of 1.414 billion yuan, a 12.16% year-on-year increase, and a net profit of 81.41 million yuan, up 23.8% year-on-year [2][7] Cost and Investment - The sales expense ratio for 25H1 was 48.94%, up 2.1 percentage points year-on-year, primarily due to increased online traffic costs [3][8] - R&D expense ratio for 25H1 was 1.75%, reflecting a 0.36 percentage point increase year-on-year, with a focus on building a global R&D team [3][8] Brand Development - The company has made significant progress in transforming its proprietary brands towards high-end and global markets, with the French luxury skincare brand EDB performing well in high-end retail venues [4][9] - The RV brand in the U.S. maintained stable growth and successfully expanded into the Mexican and Central American markets [4][9] - Emerging mid-luxury beauty brand VAA achieved a repurchase rate of 36% and a growth rate exceeding 50% in 25H1 [4][9]

Core Insights - The company reported a revenue of 2.5 billion yuan for 1H25, representing a year-on-year increase of 9.0%, with a net profit attributable to shareholders of 123 million yuan, up 16.5% [1] - In Q2 2025, the revenue reached 1.414 billion yuan, reflecting a growth of 12.2%, and the net profit attributable to shareholders was 81 million yuan, an increase of 23.8% [1] Revenue Breakdown - The revenue from facial masks in 1H25 was 423 million yuan, growing by 18.0%, with a gross margin of 73.0%, up 5.1 percentage points [1] - The revenue from lotions and creams was 1.997 billion yuan, an increase of 11.7%, with a gross margin of 62.0%, up 3.5 percentage points [1] - Revenue from the Taobao channel was 595 million yuan, up 3.6%, while revenue from Douyin reached 998 million yuan, growing by 16.1% [1] Profitability and Costs - The overall gross margin for 1H25 was 64.6%, an increase of 3.1 percentage points, and the net profit margin was 4.9%, up 0.3 percentage points [1] - The expense ratios for sales, management, and R&D were 48.9%, 5.2%, and 1.8%, respectively, with year-on-year increases of 2.1 percentage points, 0.5 percentage points, and 0.4 percentage points [1] Product and Channel Development - The company has successfully completed the high-end and global transformation of its proprietary brand system, with significant growth in key products such as the EDB super mask and collagen essence water [1] - EDB's online sales through self-broadcasting and flat sales are increasing, while offline, the company has opened 8 direct stores in high-end malls in Shanghai [2] - The company has established a CP system covering skincare, makeup, personal care, perfume, and health food, with notable sales achievements in various product lines [2] Future Outlook - The company is expected to stabilize its operations in 2025 and continue building its high-end brand matrix, with projected net profits of 252 million yuan, 319 million yuan, and 386 million yuan for 2025-2027 [2]

Investment Rating - The report upgrades the investment rating of the company to "Buy" [1] Core Views - The company has shown a quarter-on-quarter improvement in revenue growth and net profit in Q2 2025, indicating effective business structure optimization [5][9] - The company's self-owned brand revenue has increased to 41.6% of total revenue, with significant growth in key product categories such as lotions and masks [6] - The high-end beauty group strategy is progressing well, with expectations for continued revenue and profit growth from key brands [9] Financial Performance - In H1 2025, the company achieved a revenue of 2.5 billion yuan, a year-on-year increase of 9%, and a net profit attributable to shareholders of 120 million yuan, up 16.5% [5] - The gross margin improved by 3.1 percentage points to 64.6% in H1 2025, with self-owned brands achieving a gross margin of 76.8% [7] - Operating cash flow turned positive with a net inflow of 170 million yuan, reflecting improved operational efficiency [8] Business Segmentation - Self-owned brands generated 1.04 billion yuan in revenue, while agency brands accounted for 1.46 billion yuan [6] - Online sales contributed 90% of total revenue, with significant growth in third-party platforms like Taobao and Douyin [6] Future Projections - The company expects to achieve net profits of 290 million yuan, 350 million yuan, and 430 million yuan for the years 2025, 2026, and 2027 respectively, with corresponding EPS of 0.74, 0.90, and 1.10 yuan [10] - The report anticipates a revenue growth rate of 17.5% in 2025, followed by 16.4% and 16.8% in the subsequent years [10]

Core Insights - The company reported a revenue of 2.5 billion yuan for the first half of 2025, representing a year-on-year increase of 9%, and a net profit attributable to shareholders of 120 million yuan, up 16.5% year-on-year [1] - The growth rate accelerated in the second quarter, with revenue and net profit increasing by 12.2% and 23.8% respectively compared to the first quarter [1] Revenue Breakdown - Own brand revenue accounted for 41.6% of total revenue, with significant growth in key categories such as lotions and masks, achieving double-digit revenue growth [2] - Total revenue from own brands reached 1.04 billion yuan in the first half of 2025, while agency brand revenue was 1.46 billion yuan [2] - Online and offline channel revenues were 90% and 10% respectively, with online revenue growing by 9.7% and offline by 3% year-on-year [2] Product Performance - Revenue from lotions and masks constituted 80% and 17% of total revenue, with respective year-on-year growth of 11.7% and 18% [3] - Gross margin improved by 3.1 percentage points to 64.6%, with own brand gross margin at 76.8%, up 5.7 percentage points [3] Financial Metrics - The company experienced an increase in expense ratio by 3.2 percentage points to 57.5%, driven by higher sales and management expenses [3][4] - Inventory decreased by 8.9% year-on-year to 810 million yuan, with inventory turnover days at 166 days, down 5 days [4] - Accounts receivable decreased by 13.2% year-on-year to 400 million yuan, with turnover days at 27 days, down 7 days [4] Strategic Outlook - The high-end beauty group strategy is progressing well, with expectations for performance improvements as brand presence expands [5] - The company anticipates continued growth in own brand business, with upward revisions to net profit forecasts for 2025-2027 [5] - The company plans to enhance brand positioning and customer engagement through the opening of new stores and innovative customer experiences [5]

| 项目 | 2024年中报 | 2025年中报 | 同比增幅 | | --- | --- | --- | --- | | 营业总收入(元) | 22.93亿 | 25亿 | 9.02% | | 归母净利润(元) | 1.06亿 | 1.23亿 | 16.54% | | 扣非净利润(元) | 1.19亿 | 1.21亿 | 1.04% | | 货币资金(元) | 3.79亿 | 4.77 Z | 25.96% | | 应收账款(元) | 4.59亿 | 2666'E | -13.24% | | 有息负债(元) | 14.94亿 | 16.24亿 | 8.73% | | 毛利率 | 61.48% | 64.61% | 5.09% | | 净利率 | 4.77% | 4.94% | 3.75% | | 三费占营收比 | 52.91% | 55.75% | 5.36% | | 每股净资产 (元) | 5.28 | 5.29 | 0.27% | | 每股收益(元) | 0.27 | 0.32 | 17.41% | | 每股经营性现金流(元) | -0.16 | 0.43 | 368.05% | 财务报表中对有大幅变动 ...

2025 年半年度跟踪报告 | 保荐人名称：华泰联合证券有限责任公司 | 被保荐公司简称：水羊股份 | | --- | --- | | 保荐代表人姓名：张磊清 | 联系电话：0755-82492010 | | 保荐代表人姓名：陈亿 | 联系电话：0755-82492010 | 华泰联合证券有限责任公司 关于水羊集团股份有限公司 一、保荐工作概述 | 项目 | 工作内容 | | --- | --- | | 1.公司信息披露审阅情况 | | | （1）是否及时审阅公司信息披露文件 | 是 | | （2）未及时审阅公司信息披露文件的次数 | 0 次 | | 2．督导公司建立健全并有效执行规章制度的情况 | | | （1）是否督导公司建立健全规章制度（包括 | | | 但不限于防止关联方占用公司资源的制度、 | 是 | | 募集资金管理制度、内控制度、内部审计制 | | | 度、关联交易制度） | | | （2）公司是否有效执行相关规章制度 | 是 | | 3.募集资金监督情况 | | | （1）查询公司募集资金专户次数 | 每月一次 | | （2）公司募集资金项目进展是否与信息披露 | 根据 2025 年 4 月 ...

Investment Rating - The investment rating for the company is "Buy" with a target price not specified [6][17]. Core Insights - The company reported a revenue of 2.5 billion yuan for H1 2025, representing a year-on-year increase of 9.02%, and a net profit attributable to shareholders of 123 million yuan, up 16.54% year-on-year [1]. - The gross margin improved significantly to 64.61% in H1 2025, an increase of 3.13 percentage points year-on-year, driven by an increase in the proportion of proprietary brands [2]. - The company is focusing on a dual business strategy of proprietary brands and CP brand operations, with proprietary brand revenue reaching 1.039 billion yuan in H1 2025, accounting for 41.55% of total revenue [3]. - The company is building a global high-end beauty group, enhancing its brand matrix and achieving significant sales growth through various marketing strategies [4]. Financial Performance Summary - For H1 2025, the company achieved a revenue of 2.5 billion yuan and a net profit of 123 million yuan, with a gross margin of 64.61% [1][2]. - The company expects revenues of 4.655 billion yuan, 4.968 billion yuan, and 5.290 billion yuan for 2025, 2026, and 2027 respectively, with net profits projected at 250 million yuan, 320 million yuan, and 400 million yuan for the same years [4][11]. - The company’s financial ratios indicate a projected PE of 33x for 2025, decreasing to 21x by 2027 [4][11].

证券代码：300740 证券简称：水羊股份 债券代码：123188 债券简称：水羊转债 水羊集团股份有限公司投资者关系活动记录表 编号：2025-004 | 投资者关系活动 | 特定对象调研 分析师会议 媒体采访 业绩说明会 ☐ ☐ ☐ | | --- | --- | | 类别 | | | | 新闻发布会 路演活动 现场参观 其他 ☐ ☐ ☐ ☐ | | | 中信证券、中信建投证券、中泰证券、中欧基金管理、中国太平洋保险、 | | | 中国平安保险、中国国际金融、浙商证券、浙江象舆行投资管理、招商银 | | | 行、长信基金、长江证券(上海)资产管理、长江证券、长安基金、粤佛基 | | | 金、甬兴证券、兴业证券、兴业基金、信达证券、新华基金、溪牛投资管 | | | 理、西部证券、天治基金、天风证券、太平养老保险、四川诚富投资管理、 | | | 四川博金汇股权投资基金、世纪证券、深圳中胤信弘投资、深圳市长青藤 | | | 资产管理、深圳市兴亿投资管理、深圳市新高投资管理、深圳市尚诚资产 | | | 管理、深圳市凯丰投资管理、深圳市华安合鑫私募证券基金、深圳前海华 | | | 杉投资管理、深圳光峰科技、上海中 ...

Market Overview - The hair medical concept sector declined by 1.01% as of the market close on August 22, ranking among the top decliners in concept sectors [1] - Major stocks in the sector that experienced significant declines include Shuiyang Co., Huabang Health, and Baicheng Pharmaceutical, while stocks that saw gains include Zhendong Pharmaceutical, Kangyuan Pharmaceutical, and International Medicine, with increases of 1.33%, 0.69%, and 0.37% respectively [1] Concept Sector Performance - The top-performing concept sectors today include: - China AI 50: +5.31% - National Big Fund Holdings: +5.00% - SMIC Concept: +3.67% - MCU Chips: +3.64% - Automotive Chips: +3.46% [2] - Conversely, the hair medical sector was among the worst performers, alongside soybean and high-pressure oxygen chamber sectors, which saw declines of 0.94% and 0.76% respectively [2] Capital Flow Analysis - The hair medical concept sector experienced a net outflow of 289 million yuan, with 15 stocks seeing net outflows and 10 stocks exceeding 10 million yuan in outflows [2] - The stock with the highest net outflow was Shuiyang Co., with a net outflow of 123.37 million yuan, followed by Kids King, Jiu Zhi Tang, and Kang En Bei with net outflows of 84.69 million yuan, 48.68 million yuan, and 23.36 million yuan respectively [2] - Stocks with the highest net inflows included Kangyuan Pharmaceutical, Zhendong Pharmaceutical, and Xianju Pharmaceutical, with net inflows of 42.76 million yuan, 31.16 million yuan, and 21.98 million yuan respectively [2][3] Individual Stock Performance - Notable declines in the hair medical sector include: - Shuiyang Co.: -4.82% with a turnover rate of 11.16% and a net outflow of 123.37 million yuan - Kids King: -0.16% with a turnover rate of 4.36% and a net outflow of 84.69 million yuan - Jiu Zhi Tang: -1.92% with a turnover rate of 5.92% and a net outflow of 48.68 million yuan [2] - Stocks with positive performance include: - Zhendong Pharmaceutical: +1.33% with a turnover rate of 6.15% and a net inflow of 31.16 million yuan - Kangyuan Pharmaceutical: +0.69% with a turnover rate of 4.39% and a net inflow of 42.76 million yuan [3]

Investment Rating - The investment rating for the company is "Buy" (maintained) [7] Core Views - The company has experienced a recovery in performance in H1 2025 after a brand structure adjustment in 2024, with self-owned brand revenue reaching 1.039 billion yuan, accounting for 41.55% of total revenue, and a gross margin of 76.83%, an increase of 5.7 percentage points year-on-year [5][14] - The company focuses on high-end brand development and brand structure optimization, which has significantly improved overall gross margins [5][14] - The company is committed to empowering brands through research and digitalization, implementing a comprehensive R&D system and enhancing collaboration efficiency across multiple brands and channels [15] Financial Performance and Forecast - In H1 2025, the company achieved operating revenue of 2.5 billion yuan, a year-on-year increase of 9.02%, and a net profit attributable to shareholders of 123 million yuan, up 16.54% year-on-year [13] - Revenue projections for 2025-2027 are 4.590 billion yuan, 4.889 billion yuan, and 5.150 billion yuan, with corresponding growth rates of 8.3%, 6.5%, and 5.3% [16] - Net profit attributable to shareholders is expected to be 247 million yuan, 322 million yuan, and 363 million yuan for 2025-2027, with growth rates of 124.4%, 30.4%, and 13.0% respectively [16] - Earnings per share (EPS) are projected to be 0.63 yuan, 0.82 yuan, and 0.93 yuan for 2025-2027 [16] Key Financial Metrics - The company has a total share capital of 390 million shares and a circulating A-share market value of 7,740.38 million yuan [8] - The asset-liability ratio stands at 48.99% [8] - The highest and lowest stock prices in the past year were 22.36 yuan and 9.60 yuan respectively [8]